Amyloid-β PET Classification on Cognitive Aging Stages Using the Centiloid Scale

Giordana Salvi de Souza*, Michele Alberton Andrade, Wyllians Vendramini Borelli, Lucas Porcello Schilling, Cristina Sebastião Matushita, Mirna Wetters Portuguez, Jaderson Costa da Costa, Ana Maria Marques da Silva

*Corresponding author voor dit werk

OnderzoeksoutputAcademicpeer review

9 Citaten (Scopus)

Samenvatting

Propose: This study aims to explore the use of the Centiloid (CL) method in amyloid-β PET quantification to evaluate distinct cognitive aging stages, investigating subjects’ mismatch classification using different cut-points for amyloid-β positivity.

Procedures: The CL equation was applied in four groups of individuals: SuperAgers (SA), healthy age-matched controls (AC), healthy middle-aged controls (MC), and Alzheimer’s disease (AD). The amyloid-β burden was calculated and compared between groups and quantitative variables. Three different cut-points (Jack CR, Wiste HJ, Weigand SD, et al., Alzheimer’s Dement 13:205–216, 2017; Salvadó G, Molinuevo JL, Brugulat-Serrat A, et al., Alzheimer’s Res Ther 11:27, 2019; and Amadoru S, Doré V, McLean CA, et al., Alzheimer’s Res Ther 12:22, 2020) were applied in CL values to differentiate the earliest abnormal pathophysiological accumulation of Aβ and the established Aβ pathology.

Results: The AD group exhibited a significantly increased Aβ burden compared to the MC, but not AC groups. Both healthy control (MC and AC) groups were not significantly different. Visually, the SA group showed a diverse distribution of CL values compared with MC; however, the difference was not significant. The CL values have a moderate and significant relationship between Aβ visual read, RAVLT DR and MMSE. Depending on the cut-point used, 10 CL, 19 CL, or 30 CL, 7.5% of our individuals had a different classification in the Aβ positivity. For the AC group, we obtained about 40 to 60% of the individuals classified as positive.

Conclusion: SuperAgers exhibited a similar Aβ load to AC and MC, differing in cognitive performance. Independently of cut-point used (10 CL, 19 CL, or 30 CL), three SA individuals were classified as Aβ positive, showing the duality between the individual’s clinics and the biological definition of Alzheimer’s. Different cut-points lead to Aβ positivity classification mismatch in individuals, and an extra care is needed for individuals who have a CL value between 10 and 30 CL.

Originele taal-2English
Pagina's (van-tot)394-403
Aantal pagina's10
TijdschriftMolecular Imaging and Biology
Volume24
Nummer van het tijdschrift3
DOI's
StatusPublished - jun.-2022
Extern gepubliceerdJa

Vingerafdruk

Duik in de onderzoeksthema's van 'Amyloid-β PET Classification on Cognitive Aging Stages Using the Centiloid Scale'. Samen vormen ze een unieke vingerafdruk.

Citeer dit